Media coverage
109
Media coverage
Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Pharma Focus Asia Country/Territory India Date 9/11/22 URL ct.moreover.com/?a=49206983636&p=1gw&v=1&x=qVIZCibZXwGgkjnu8ZQ7Fw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Regeneron Country/Territory United States Date 9/11/22 URL ct.moreover.com/?a=49204414618&p=1gw&v=1&x=1UZm5mg66TpBI7mrvBPk_Q Persons Israel Lowy, Title Libtayo® (Cemiplimab-Rwlc) In Combination With Chemotherapy Approved By The FDA As First-Line Treatment For Advanced Non-Small Cell Lung Cancer (NSCLC)' Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 8/11/22 URL ct.moreover.com/?a=49203612796&p=1gw&v=1&x=mgRRhGTe6sqEVNwSBsaCWw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Morningstar.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203140440&p=1gw&v=1&x=mhelju5bimnBsd6p6sbPPA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet PR Newswire Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203206286&p=1gw&v=1&x=tEzporVimBBx98EJJ6C4CA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Street Insider Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203062579&p=1gw&v=1&x=GyROGBO3_U9SLGc9jz9mcg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet BioSpace Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49204812514&p=1gw&v=1&x=EaAOIz0hUenoMrY8c_a5MA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced.. Media name/outlet ADVFN UK Country/Territory United Kingdom Date 8/11/22 URL ct.moreover.com/?a=49203058993&p=1gw&v=1&x=4LbPZWGDQb_gFnn_IaqkJQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Yahoo! News Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203065801&p=1gw&v=1&x=5JMpngpPzTYobQr6Deskyg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet ADVFN UK Country/Territory United Kingdom Date 8/11/22 URL ct.moreover.com/?a=49203070336&p=1gw&v=1&x=sxIJfhwNWwJ2wkbzIuAujA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Yahoo! Finanzas Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203072219&p=1gw&v=1&x=JE9Iwsws5wcfpqt0MsG0vA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Yahoo! Finance Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203121083&p=1gw&v=1&x=dX-schCPOwdHuOx8_v1oow Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Finanzen.ch Country/Territory Switzerland Date 8/11/22 URL ct.moreover.com/?a=49204823103&p=1gw&v=1&x=-cnuInZDvKqWyyV0IrpWLw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet MarketScreener.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203069196&p=1gw&v=1&x=1LSS_4IV1i9sx0IjRcE9sw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet APNews.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203133911&p=1gw&v=1&x=Yt_k9_HIesy8Sk-wknqV-g Persons Israel Lowy, Title Libtayo (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Chase Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203068909&p=1gw&v=1&x=PId5klHTNueC4EI8WWs1EQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet ADVFN US Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203080714&p=1gw&v=1&x=ni2XiHTgaEFA_X7f0dqVyg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet TickerTech.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203081460&p=1gw&v=1&x=zKKH6xu5voknSnx0J-0uNg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Markets Business Insider Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203082838&p=1gw&v=1&x=z4g16aP464J_BOIj0uHEWg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet ProfitQuotes.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203082857&p=1gw&v=1&x=Lk4Af_2Td1Vn9N8Z7tWxGA Persons Israel Lowy, Title Libtayo ‚ ® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Stockwatch Country/Territory Canada Date 8/11/22 URL ct.moreover.com/?a=49203104605&p=1gw&v=1&x=H-XjbRB4VIbon1j60cD7rA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Canadian Insider Country/Territory Canada Date 8/11/22 URL ct.moreover.com/?a=49203194296&p=1gw&v=1&x=B3PjYB16QR1mMZBequdVpA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Spoke.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203273945&p=1gw&v=1&x=BAwCH_mYrKY4nLMlYoWxTA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Webcenter 11 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203105395&p=1gw&v=1&x=_2t19-cz8kHHl4CCkNvhIA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Upper Michigans Source Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203106288&p=1gw&v=1&x=_R6wLXEz7mimlkvJcIhltA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WTVM Country/Territory Georgia Date 8/11/22 URL ct.moreover.com/?a=49203107111&p=1gw&v=1&x=vtBmJ9_GzX2IXl7nFry5Mg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Kait 8 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203113783&p=1gw&v=1&x=PSD_js4xdqYR5FhUZrUXHg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KLTV 7 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203108415&p=1gw&v=1&x=V9JNns8Gl-PAwIF-5J19FQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KOLO TV Reno Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203113536&p=1gw&v=1&x=wt1f7L0jWLbYOC0pnhvFxA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet NewsChannel 10 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203116154&p=1gw&v=1&x=sQPZ261WrgwvtCUD51GkVg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WAFB Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203117409&p=1gw&v=1&x=MoGQVY071pycFNGonbY35Q Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet NBC15 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203117510&p=1gw&v=1&x=qmHd-Nb7cAqXhxTG2pfOIg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WCJB Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203117502&p=1gw&v=1&x=biksyx53WflrGhwcO3JtCQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Fox 19 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203118810&p=1gw&v=1&x=mtumDQDlHRHYtLc5p-s6nA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KEYC Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203119962&p=1gw&v=1&x=8KeZWO48Z7blfSTMPptJJw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet 14 WFIE Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203120965&p=1gw&v=1&x=p-gngPkc1GuUYP1_u1V4Qg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WHSV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203122371&p=1gw&v=1&x=RHgXgXX4_r2F36O9oIJCFA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WLOX Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203122036&p=1gw&v=1&x=K0C112s1LQ8K9rONFaiwsQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KCRG.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203124533&p=1gw&v=1&x=zyFrjhYQ00IY-RNkkVgdNg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WALB 10 Country/Territory Georgia Date 8/11/22 URL ct.moreover.com/?a=49203131282&p=1gw&v=1&x=u_hBmb-qdl3x6ik4x8nv9g Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WKYT Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203131202&p=1gw&v=1&x=Y6k7d8_B4tKDrQsfC2cNwQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WDTV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203131877&p=1gw&v=1&x=IFhVyhzjLnAqTmh8zdtlBg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WLBT Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203131796&p=1gw&v=1&x=6rdWPIc-VM-N9BWeEgm6Yw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KKTV.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203125735&p=1gw&v=1&x=EikX3fHRMpLJP6lhvrgmZw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Hawaii News Now Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203125748&p=1gw&v=1&x=HT2y6f6eqt6O78ZBdOhhPA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Live 5 WCSC Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203128616&p=1gw&v=1&x=BGbErjPV3nnkILhA_zwNSA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WBRC Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203129005&p=1gw&v=1&x=mAnTgQB2akJzSA1lP4vUzQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Wave 3 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203128400&p=1gw&v=1&x=DF6QX_LU2mT3qdkP0062bQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WCTV6 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203132818&p=1gw&v=1&x=mBeHey7SuoU5hMgehdpVBg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WBKO Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203133657&p=1gw&v=1&x=BsD-YVzhWR7jbndxB-Ncjw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KCBD Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203134031&p=1gw&v=1&x=tyYmj303Wozi4_ZjFJp6MA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KWTX Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203134512&p=1gw&v=1&x=Mw1pvsBiPymYpuDw48LtWg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WWNY TV 7 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203137444&p=1gw&v=1&x=LhinF2DqJDx58rnoZXQmrg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KYTV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203139151&p=1gw&v=1&x=FAX6Ni1BXgQoCqBUDtEI4Q Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet NBC12 Online Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203136795&p=1gw&v=1&x=oVz3IT32Xams-YYFlYNmMw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WDAM-TV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203139496&p=1gw&v=1&x=a-UAuPo-FvDTMeq9qIKluw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WSAZ Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203136965&p=1gw&v=1&x=XGwcBtTGGiQoBP1GA23LcA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KFVS12 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203139596&p=1gw&v=1&x=wezxQQJ53REqoPPKEZONqw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Fox 8 WVUE New Orleans Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203142964&p=1gw&v=1&x=rqDJoyYN1RAK2RJ2i8T1ug Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KBTX.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203143447&p=1gw&v=1&x=fmsHVTfEGZiGifv4amuPbg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KSNB Local4 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203144331&p=1gw&v=1&x=vBhFPUxIVQn3Gx7AeYEAuQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet NBC 11 News Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203147514&p=1gw&v=1&x=Yd7yl0PTMMiXuSlgNs-bJg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WCAX TV3 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203148313&p=1gw&v=1&x=ORkK15OuUbEMlUBThsDyRw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WVLT Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203151409&p=1gw&v=1&x=CU3BchbgU3o0m3vSIJAwDQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WECT TV-6 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203165546&p=1gw&v=1&x=fg98nmWlypBQDtNc6SYAqw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet NBCNebraskaScottsbluff.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203172713&p=1gw&v=1&x=0xl4hLd7UcbhNQcZi5CMag Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WSFA Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203170584&p=1gw&v=1&x=wHN9Iy7DaDKpB9agUUgk3g Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Port Arthur News Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203111986&p=1gw&v=1&x=_VeHr_h08Sd-tYTghLuQqA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Winchester Sun Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203117344&p=1gw&v=1&x=EcjUq7O4JJyW_ZR9vxpy9Q Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Suffolk News Herald Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203120284&p=1gw&v=1&x=tUZfWbugA3lsSwxkWG8CWQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Salisbury Post Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203120757&p=1gw&v=1&x=ovcUpBH4dzxkFTeK7vWvTQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Elizabethton.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203122222&p=1gw&v=1&x=oVdBYH-ywsNW_3-lUZ9LFw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Smithfield Times Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203139395&p=1gw&v=1&x=jxhkFfPupjcQOKSSCmcRTQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Media name/outlet Jessamine Journal Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203141319&p=1gw&v=1&x=9DQkZEOYlA_YphAWIQ1-IQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet MyPanhandle.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203164223&p=1gw&v=1&x=7b6OXBZ4yeYJ2p-b20HG4g Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet PIX11 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203176696&p=1gw&v=1&x=jmMmImh-mWBaGsMP0IQMzQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WTen.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203181777&p=1gw&v=1&x=iKzdbNNmbSz64AOzBHJOrA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WRIC TV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203205465&p=1gw&v=1&x=35BFsJNTjW3XT1TmYuCApQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Fox 16 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203205951&p=1gw&v=1&x=Qjwg77fNmy8EQOr-7eb2Yw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WATE Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203222201&p=1gw&v=1&x=89yYALg_HGopuqV8c7Cc0A Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KRQE Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203224004&p=1gw&v=1&x=lzzCqvQdX-OtQdF_hO416Q Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet FOX5 San Diego Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203240186&p=1gw&v=1&x=AHAODXJ5UEMaIzGCswjZOw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet ABC 27 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203243818&p=1gw&v=1&x=tJfFNmnON4O0ybqfZbkmWg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet 8 News Now Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203249940&p=1gw&v=1&x=R1xDhvU5kJPAuL0FaIH4Rg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WREG Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203250268&p=1gw&v=1&x=n805odTUZ8sRpFYtcGlJDw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WHNT-TV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203258953&p=1gw&v=1&x=tNFdoA78MPhWWdzhR-Z5uw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WGN-TV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203259235&p=1gw&v=1&x=PiiEWP2aL5_36MeUFNAwHQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KOIN Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203265397&p=1gw&v=1&x=9qwnjz1HW2Cu9Im5vCLUZg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet NBC4 Columbus Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203272001&p=1gw&v=1&x=OVXtC_Bb8bUFVipTgIVwBw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet CW39 NewsFix Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203278109&p=1gw&v=1&x=X_5I9aif4-isP7AprquUGQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WANE-TV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203293272&p=1gw&v=1&x=wjbpVrD0RlmefyIhq1iFqA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet YOUR BASIN Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203301483&p=1gw&v=1&x=FI0tGAqLfslrjK8Sf_4EQw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KXAN Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203302175&p=1gw&v=1&x=m_NxWunAAm_X6O31I00A3Q Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WIVB Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203302380&p=1gw&v=1&x=RaomyksFjuq-1f6KINTYiw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Everything Lubbock Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203307094&p=1gw&v=1&x=7Bk16iNFaDMzPOA21iOmKA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KFOR.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203308940&p=1gw&v=1&x=Q093nXph8zR8vShV-pIcqg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet KTLA Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203317043&p=1gw&v=1&x=TS65FRXnQr1kd9PRmaiL6w Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Wavy Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203317599&p=1gw&v=1&x=7J-g_eagGrxf_nsf-21wmw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WKBN 27 First News Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203320109&p=1gw&v=1&x=FUI7TBl7qlJyUiPL12LRsA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Wood TV Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203326245&p=1gw&v=1&x=Dy_MvwGlo8Ju6QhyF6aOwQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WKRN Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203338417&p=1gw&v=1&x=iJT7jVrwTZE4dw-Fo3O7jw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Siouxland Matters Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203339689&p=1gw&v=1&x=m566X2WmlLDQ_3KsE8eJpw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet FOX 31 News KDVR Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203341306&p=1gw&v=1&x=BTg00y8tvl7QgbgcQ9W5qg Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WJHL.com Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203341669&p=1gw&v=1&x=iju3dj4xcKR11DNqe9VdKQ Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet FOX 59 Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203342493&p=1gw&v=1&x=rv-43J7Rwf8gCqkyN7LvFw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WTWO Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203362744&p=1gw&v=1&x=dFST5pYBV6RE2rBVGCCPDw Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet WGNO Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203371222&p=1gw&v=1&x=-qvr1VgJr2v3d-esKuneeA Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet FOX8 WGHP Country/Territory United States Date 8/11/22 URL ct.moreover.com/?a=49203382885&p=1gw&v=1&x=6HPnBiy8v1V88taEwh6N8A Persons Israel Lowy, Title Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC) Media name/outlet Central Charts Country/Territory France Date 8/11/22 URL ct.moreover.com/?a=49203083424&p=1gw&v=1&x=89GLZzc0nt8CKcXq_IWfow Persons Israel Lowy,